Currently out of the existing stock ratings of Oren Livnat, 14 are a HOLD (7.53%), 172 are a BUY (92.47%).

Oren Livnat

Work Performance Price Targets & Ratings Chart

Analyst Oren Livnat works with a stock forecast success ratio of 31.8% fulfilled within 183.96 days on average. Previously, Oren Livnat worked at HCWAINWRIGHT.

Oren Livnat’s has documented 347 price targets and ratings displayed on 23 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on XERS, Xeris Pharmaceuticals at 07-Mar-2024.

Wall Street Analyst Oren Livnat

Analyst best performing recommendations are on MNLO (MENLO THERAPEUTICS).
The best stock recommendation documented was for MNLO (MENLO THERAPEUTICS) at 5/12/2020. The price target of $2.5 was fulfilled within 16 days with a profit of $0.69 (38.12%) receiving and performance score of 23.83.

Average potential price target upside

PCRX Pacira Pharmaceuticals AERI Aerie Pharmaceuticals . AGRX Agile Thrpe ATRS Antares Pharma BDSI BioDelivery Sciences International COLL Collegium Pharmaceutical KMPH KemPharm SCYX Scynexis NOVN Novan VRCA Verrica Pharmaceuticals STSA Satsuma Pharmaceuticals XERS Xeris Pharmaceuticals ANIP ANI Pharmaceuticals AVDL Avadel Pharmaceuticals PLC CARA Cara Therapeutic JAZZ Jazz Pharmaceuticals PLC MNKD MannKind Corp TARS Tarsus Pharmaceuticals  LPCN Lipocine MNLO Menlo Therapeutics OTIC Otonomy VYNE Vyne Therapeutics ZYNE Zynerba Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

45

$15.96 (54.96%)

83

22 days ago

1/3 (33.33%)

$14.36 (46.87%)

239

Buy

57

$27.96 (96.28%)

57

25 days ago

13/23 (56.52%)

$27.8 (95.21%)

233

Buy

45

$15.96 (54.96%)

45

28 days ago

2/12 (16.67%)

$16.14 (55.93%)

878

Buy

45

$15.96 (54.96%)

58

28 days ago

0/5 (0%)

$16.14 (55.93%)

Buy

57

$27.96 (96.28%)

60

1 months 21 days ago

0/2 (0%)

$29.3 (105.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Oren Livnat is most bullish on?

Potential upside of $27.96 has been obtained for PCRX (PACIRA PHARMACEUTICALS)

Which stock is Oren Livnat is most reserved on?

Potential downside of $1.45 has been obtained for CARA (CARA THERAPEUTIC)

What Year was the first public recommendation made by Oren Livnat?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?